Clinical Trials
13
Active:0
Completed:2
Trial Phases
3 Phases
Phase 2:3
Phase 3:1
Not Applicable:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Not Applicable
4 (50.0%)Phase 2
3 (37.5%)Phase 3
1 (12.5%)Efficacy and Safety of Ultra_HYPofractionated RadiotHerapy in Women With BrEast CaNcer Receiving Regional Nodal Radiation vs Nodal Moderate Hypofractionated Radiotherapy
Not Applicable
Recruiting
- Conditions
- Malignant Breast Neoplasm
- First Posted Date
- 2022-12-27
- Last Posted Date
- 2022-12-29
- Lead Sponsor
- Instituto Brasileiro de Controle do Cancer
- Target Recruit Count
- 36
- Registration Number
- NCT05665920
- Locations
- 🇧🇷
IBCC Oncologia, Sao Paulo, SP, Brazil
Transgender Observational Performance
- Conditions
- Transgender Persons
- First Posted Date
- 2022-04-20
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- Instituto Brasileiro de Controle do Cancer
- Target Recruit Count
- 60
- Registration Number
- NCT05337865
Prognostic Value of Circulating Tumor DNA Dosing in Patients in Neoadjuvant Breast Neoplasia
- Conditions
- Breast Neoplasm
- First Posted Date
- 2021-09-21
- Last Posted Date
- 2021-09-30
- Lead Sponsor
- Instituto Brasileiro de Controle do Cancer
- Target Recruit Count
- 38
- Registration Number
- NCT05050890
- Locations
- 🇧🇷
IBCC Oncologia, Sao Paulo, SP, Brazil
Breast Cancer Survivors: Main Physical and Psychosocial Problems After Completion of Treatment
- Conditions
- Breast Cancer
- First Posted Date
- 2021-04-08
- Last Posted Date
- 2021-04-08
- Lead Sponsor
- Instituto Brasileiro de Controle do Cancer
- Target Recruit Count
- 105
- Registration Number
- NCT04834570
- Locations
- 🇧🇷
IBCC Oncologia, São Paulo, Brazil
Hydration Based on Thoitaine, Aloe Vera and Calendula, in the Prevention of Hand-Foot Syndrome in Patients Using Capecitabine
- First Posted Date
- 2021-04-06
- Last Posted Date
- 2021-04-06
- Lead Sponsor
- Instituto Brasileiro de Controle do Cancer
- Target Recruit Count
- 54
- Registration Number
- NCT04833998
- Locations
- 🇧🇷
IBCC Oncologia, São Paulo, Brazil
- Prev
- 1
- 2
- 3
- Next
News
No news found